Raising Awareness in April for Better Outcomes for People Living With Irritable Bowel Syndrome (IBS)

Share on: 

April is National Irritable Bowel Syndrome (IBS) Awareness month. We’re proud to contribute to research to widen understanding and improve the lives of the as many as 1 in 5 people in the US living with IBS. Our experience consists of 25+ researchers with expertise in gastroenterology, including IBS research such as:

Camilleri M, Lembo AJ, Lavins BJ, Macdougall JE, Carson RT, Williams VSLNelson LM, Shiff SJ, Currie MG, Kurtz CB, Johnston JM. Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C.

Ervin CMMangel AWClinical Trials in Irritable Bowel Syndrome: A Review.

Mangel AWWhat should be the primary end point in irritable bowel syndrome?

Mangel AW, Hicks GA. Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: A review.

Read more about this research and the 60+ other IBS-related publications by RTI-HS authors on our Publications page.

Related Services: